213 related articles for article (PubMed ID: 24053204)
1. Chemoselection: a paradigm for optimization of organ preservation in locally advanced larynx cancer.
Vainshtein JM; Wu VF; Spector ME; Bradford CR; Wolf GT; Worden FP
Expert Rev Anticancer Ther; 2013 Sep; 13(9):1053-64. PubMed ID: 24053204
[TBL] [Abstract][Full Text] [Related]
2. Single-cycle induction chemotherapy selects patients with advanced laryngeal cancer for combined chemoradiation: a new treatment paradigm.
Urba S; Wolf G; Eisbruch A; Worden F; Lee J; Bradford C; Teknos T; Chepeha D; Prince M; Hogikyan N; Taylor J
J Clin Oncol; 2006 Feb; 24(4):593-8. PubMed ID: 16380415
[TBL] [Abstract][Full Text] [Related]
3. Functional organ preservation in locally advanced laryngeal squamous cell carcinoma: is there a role for induction chemotherapy?
Loo SW; Geropantas K; Roques TW
Clin Oncol (R Coll Radiol); 2013 May; 25(5):298-307. PubMed ID: 23290343
[TBL] [Abstract][Full Text] [Related]
4. Voice and swallowing outcomes of an organ-preservation trial for advanced laryngeal cancer.
Fung K; Lyden TH; Lee J; Urba SG; Worden F; Eisbruch A; Tsien C; Bradford CR; Chepeha DB; Hogikyan ND; Prince ME; Teknos TN; Wolf GT
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1395-9. PubMed ID: 16087298
[TBL] [Abstract][Full Text] [Related]
5. Organ preservation for advanced larynx cancer: A review of chemotherapy and radiation combination strategies.
Bonomi MR; Blakaj A; Blakaj D
Oral Oncol; 2018 Nov; 86():301-306. PubMed ID: 30409316
[TBL] [Abstract][Full Text] [Related]
6. Selection of therapeutic treatment with alternating chemoradiotherapy for larynx preservation in laryngeal carcinoma patients.
Ijichi K; Hanai N; Kawakita D; Ozawa T; Suzuki H; Hirakawa H; Kodaira T; Murakami S; Hasegawa Y
Jpn J Clin Oncol; 2014 Nov; 44(11):1063-9. PubMed ID: 25187666
[TBL] [Abstract][Full Text] [Related]
7. Organ preservation for adenoid cystic carcinoma of the larynx.
Misiukiewicz KJ; Camille N; Tishler R; Haddad R; Limaye S; Posner M
Oncologist; 2013; 18(5):579-83. PubMed ID: 23615699
[TBL] [Abstract][Full Text] [Related]
8. From VA Larynx to the future of chemoselection: Defining the role of induction chemotherapy in larynx cancer.
Spector ME; Rosko AJ; Swiecicki PL; Chad Brenner J; Birkeland AC
Oral Oncol; 2018 Nov; 86():200-205. PubMed ID: 30409302
[TBL] [Abstract][Full Text] [Related]
9. Comparison between chemoselection and definitive radiotherapy in patients with cervical esophageal squamous cell carcinoma.
Nakata Y; Hanai N; Nishikawa D; Suzuki H; Koide Y; Fukuda Y; Nomura M; Kodaira T; Shimizu T; Hasegawa Y
Int J Clin Oncol; 2017 Dec; 22(6):1034-1041. PubMed ID: 28623448
[TBL] [Abstract][Full Text] [Related]
10. Could the Addition of Cetuximab to Conventional Radiation Therapy Improve Organ Preservation in Those Patients With Locally Advanced Larynx Cancer Who Respond to Induction Chemotherapy? An Organ Preservation Spanish Head and Neck Cancer Cooperative Group Phase 2 Study.
Mesía R; Garcia-Saenz JA; Lozano A; Pastor M; Grau JJ; Martínez-Trufero J; Lambeaz J; Martínez-Galán J; Mel JR; González B; Vázquez S; Mañós M; Taberna M; Cirauqui B; Del Barco E; Casado E; Rubió-Casadevall J; Rodríguez-Jaráiz A; Cruz JJ;
Int J Radiat Oncol Biol Phys; 2017 Mar; 97(3):473-480. PubMed ID: 28011050
[TBL] [Abstract][Full Text] [Related]
11. Comparing surgical and nonsurgical larynx-preserving treatments with total laryngectomy for locally advanced laryngeal cancer.
Patel SA; Qureshi MM; Dyer MA; Jalisi S; Grillone G; Truong MT
Cancer; 2019 Oct; 125(19):3367-3377. PubMed ID: 31206637
[TBL] [Abstract][Full Text] [Related]
12. Induction chemotherapy (IC) followed by radiotherapy (RT) versus cetuximab plus IC and RT in advanced laryngeal/hypopharyngeal cancer resectable only by total laryngectomy-final results of the larynx organ preservation trial DeLOS-II.
Dietz A; Wichmann G; Kuhnt T; Pfreundner L; Hagen R; Scheich M; Kölbl O; Hautmann MG; Strutz J; Schreiber F; Bockmühl U; Schilling V; Feyer P; de Wit M; Maschmeyer G; Jungehülsing M; Schroeder U; Wollenberg B; Sittel C; Münter M; Lenarz T; Klussmann JP; Guntinas-Lichius O; Rudack C; Eich HT; Foerg T; Preyer S; Westhofen M; Welkoborsky HJ; Esser D; Thurnher D; Remmert S; Sudhoff H; Görner M; Bünzel J; Budach V; Held S; Knödler M; Lordick F; Wiegand S; Vogel K; Boehm A; Flentje M; Keilholz U
Ann Oncol; 2018 Oct; 29(10):2105-2114. PubMed ID: 30412221
[TBL] [Abstract][Full Text] [Related]
13. Induction chemotherapy followed by radiotherapy for larynx preservation in advanced laryngeal and hypopharyngeal cancer: Outcome prediction after one cycle induction chemotherapy by a score based on clinical evaluation, computed tomography-based volumetry and
Wichmann G; Krüger A; Boehm A; Kolb M; Hofer M; Fischer M; Müller S; Purz S; Stumpp P; Sabri O; Dietz A; Kluge R
Eur J Cancer; 2017 Feb; 72():144-155. PubMed ID: 28033526
[TBL] [Abstract][Full Text] [Related]
14. Results of chemoselection with short induction chemotherapy followed by chemoradiation or surgery in the treatment of functionally inoperable carcinomas of the pharynx and larynx.
Semrau S; Schmidt D; Lell M; Waldfahrer F; Lettmaier S; Kuwert T; Iro H; Fietkau R
Oral Oncol; 2013 May; 49(5):454-60. PubMed ID: 23321550
[TBL] [Abstract][Full Text] [Related]
15. Current trends in initial management of laryngeal cancer: the declining use of open surgery.
Silver CE; Beitler JJ; Shaha AR; Rinaldo A; Ferlito A
Eur Arch Otorhinolaryngol; 2009 Sep; 266(9):1333-52. PubMed ID: 19597837
[TBL] [Abstract][Full Text] [Related]
16. Relationship between response to induction chemotherapy and disease control in patients with advanced laryngeal carcinoma included in an organ preservation protocol.
León X; Valero C; Rovira C; Rodriguez C; López M; García-Lorenzo J; Quer M
Eur Arch Otorhinolaryngol; 2017 Jun; 274(6):2581-2587. PubMed ID: 28349204
[TBL] [Abstract][Full Text] [Related]
17. Organ preservation and treatment toxicity with induction chemotherapy followed by radiation therapy or chemoradiation for advanced laryngeal cancer.
Guadagnolo BA; Haddad RI; Posner MR; Weeks L; Wirth LJ; Norris CM; Sullivan CA; Goguen L; Busse PM; Tishler R
Am J Clin Oncol; 2005 Aug; 28(4):371-8. PubMed ID: 16062079
[TBL] [Abstract][Full Text] [Related]
18. Does induction chemotherapy still have a role in larynx preservation strategies? The experience of Institut Catala d'Oncologia in stage III larynx carcinoma.
Majem M; Mesia R; Mañós M; Gomez J; Galiana R; Cardenal F; Juan A; Montes A; Perez FJ; Nogues J; Llluch JR
Laryngoscope; 2006 Sep; 116(9):1651-6. PubMed ID: 16954998
[TBL] [Abstract][Full Text] [Related]
19. Organ preservation surgery for laryngeal cancer.
Tufano RP; Stafford EM
Otolaryngol Clin North Am; 2008 Aug; 41(4):741-55, vi. PubMed ID: 18570956
[TBL] [Abstract][Full Text] [Related]
20. Clinical outcomes of 849 laryngeal cancers treated in the past 40 years: are we succeeding?
Nakayama M; Okamoto M; Hayakawa K; Miyamoto S; Ishiyama H; Komori S; Okamoto T; Seino Y; Kano K; Soda I; Sekiguchi A; Kawakami S
Jpn J Clin Oncol; 2014 Jan; 44(1):57-64. PubMed ID: 24174633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
